EU Review Time Lengthens for BMS’s CAR-T Therapy Liso-Cel

Company Wants More Time To Answer Reviewers’ Questions

 
• By Maureen Kenny
  
EU reviewers often have late-stage questions for companies • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography